amobarbital has been researched along with Inborn Errors of Metabolism in 2 studies
Amobarbital: A barbiturate with hypnotic and sedative properties (but not antianxiety). Adverse effects are mainly a consequence of dose-related CNS depression and the risk of dependence with continued use is high. (From Martindale, The Extra Pharmacopoeia, 30th ed, p565)
amobarbital : A member of the class of barbiturates that is pyrimidine-2,4,6(1H,3H,5H)-trione substituted by a 3-methylbutyl and an ethyl group at position 5. Amobarbital has been shown to exhibit sedative and hypnotic properties.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kalow, W | 1 |
| Kadar, D | 1 |
| Inaba, T | 1 |
| Tang, BK | 1 |
| Holmes, B | 1 |
| Good, RA | 1 |
2 other studies available for amobarbital and Inborn Errors of Metabolism
| Article | Year |
|---|---|
A case of deficiency of N-hydroxylation of amobarbital.
Topics: Adolescent; Adult; Aged; Alleles; Amobarbital; Biotransformation; Female; Half-Life; Humans; Hydroxy | 1977 |
Laboratory models of chronic granulomatous disease.
Topics: Amobarbital; Animals; Blood Bactericidal Activity; Chronic Disease; Dehydroepiandrosterone; Dihydrol | 1972 |